First Time Loading...

GenMont Biotech Inc
TWSE:3164

Watchlist Manager
GenMont Biotech Inc Logo
GenMont Biotech Inc
TWSE:3164
Watchlist
Price: 23.15 TWD -0.22% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
GenMont Biotech Inc

Wall Street analysts forecast GenMont Biotech Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GenMont Biotech Inc is 102 TWD .

Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
102 TWD
341% Upside
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
102 TWD
341% Upside
Highest
Price Target
Not Available
GenMont Biotech Inc Competitors:
Price Targets
INBX
Inhibrx Inc
6% Upside
T
1875
TOT BIOPHARM International Co Ltd
110% Upside
HPHA
Heidelberg Pharma AG
287% Upside
TSVT
2Seventy Bio Inc
136% Upside
INBX
Inhibrx Inc
6% Upside
T
1875
TOT BIOPHARM International Co Ltd
110% Upside
HPHA
Heidelberg Pharma AG
287% Upside
TSVT
2Seventy Bio Inc
136% Upside
002007
Hualan Biological Engineering Inc
35% Upside
C
688276
Changchun BCHT Biotechnology Co
62% Upside
i
048530
iNtRON Biotechnology Inc
139% Upside
S
096530
Seegene Inc
69% Upside

Revenue
Forecast

Revenue Estimate
GenMont Biotech Inc

Revenue forecast
is not available for
GenMont Biotech Inc

Operating Income
Forecast

Operating Income Estimate
GenMont Biotech Inc

Operating Income forecast
is not available for
GenMont Biotech Inc

Net Income
Forecast

Net Income Estimate
GenMont Biotech Inc

Net Income forecast
is not available for
GenMont Biotech Inc

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GenMont Biotech Inc's stock price target?
Price Target
102 TWD

According to Wall Street analysts, the average 1-year price target for GenMont Biotech Inc is 102 TWD .

ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.